Ocular and orbital complications following the treatment of retinoblastoma

被引:25
作者
Anteby, I
Ramu, N
Gradstein, L
Miskin, H
Pe'er, J
Benezra, D
机构
[1] Hadassah Univ Hosp, Dept Ophthalmol, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel
关键词
irradiation-cataract; radiation retinopathy; enucleation; socket;
D O I
10.1177/112067219800800210
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To investigate the ocular and orbital complications observed in children treated for retinoblastoma. Subjects and methods. We retrospectively studied 73 children (39 boys, 34 girls) suffering from retinoblastoma. Thirty-six had bilateral tumor and 37 unilateral disease for a total of 109 eyes affected. The follow-up was 6-180 months (median 36 months). Enucleation was the most common initial treatment approach in the unilateral group, and radiotherapy (by external beam) was the most common initial therapy in the bilateral group. Cryotherapy, photocoagulation, brachytherapy and/or systemic chemotherapy were used as adjuvant treatments when necessary. Ocular complications were recorded at the follow-up examinations. Results. Cataract developed in 20% of the irradiated eyes. The mean time from irradiation until development of cataract was 28.5 months (6-64 months). Radiation retinopathy developed in 12% and was first detected 11-72 months (mean 37 months) after irradiation therapy. Mild transient keratopathy was observed in all eyes undergoing irradiation, and xerophthalmia in one eye. Complications after enucleation included: marked discharge from the socket (11.0%), extrusion of the implant (9.6%), and contraction of the socket (3.0%). No complications were observed after cryotherapy or laser photocoagulation of the tumor. Conclusions. Ocular complications after treating children with retinoblastoma are common and may seriously affect the quality of life of children surviving the primary malignancy.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 29 条
[1]  
ABRAMSON DH, 1994, J PEDIATR OPHTHALMOL, V31, P32
[2]  
ABRAMSON DH, 1981, B NEW YORK ACAD MED, V57, P787
[3]  
AMENDOLA BE, 1990, CANCER, V66, P21, DOI 10.1002/1097-0142(19900701)66:1<21::AID-CNCR2820660105>3.0.CO
[4]  
2-G
[5]  
APPLE DJ, 1991, OCULAR PATHOLOGY CLI, P375
[6]   TREATMENT OF RETINOBLASTOMA AND RESULTS - LAUSANNE 1963-1989 [J].
BALMER, A ;
GAILLOUD, C ;
DEPOTTER, P ;
MUNIER, F ;
CHAMERO, J .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1990, 196 (05) :374-376
[7]  
BENEZRA D, 1977, J PEDIATR OPHTHALMOL, V13, P340
[8]  
Benezra D., 1990, EUR J IMPLANT REFRAC, V2, P241, DOI [10.1016/S0955-3681(13)80091-3, DOI 10.1016/S0955-3681(13)80091-3]
[9]   REMOVAL OF RADIATION-INDUCED CATARACTS IN PATIENTS TREATED FOR RETINOBLASTOMA [J].
BROOKS, HL ;
MEYER, D ;
SHIELDS, JA ;
BALAS, AG ;
NELSON, LB ;
FONTANESI, J .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (12) :1701-1708
[10]  
CHARLERS R, 1990, OPHTHALMIC SURG PRIN, P623